The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Initial public offerings from oil-and-gas company Infinity Natural Resources Inc. and medical-device maker Beta Bionics Inc. both rose in their stock markets debut Friday, as they brushed aside losses ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Healthcare & Pharmaceuticalscategory New case of mpox variant clade lb detected in England 1:23 PM UTC Healthcare & Pharmaceuticalscategory AbbVie forecasts 2025 profit above estimates on newer ...

The Cabinet on Friday demanded the National Assembly reconsider an opposition-proposed bill that calls for a special counsel probe into President Yoon Suk Yeol on his failed martia... South Korea on ...